Drugs / BIAsp 70
last change Aug 2006 re-read 2 minutes ago

BIAsp 70

Developed for
type 1 diabetes mellitus
Investigated by
Novo Nordisk A/S · University of Aarhus

Trials 1 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT00283218 Jan → Aug 2006 type 1 diabetes mellitus University of Aarhus Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BIAsp 70 “The profiles will be derived over a 12-hour period after subcutaneous injection in the abdominal region with a single dose of IAsp, BIAsp 30, BIAsp 50 or BIAsp 70 at a test meal.” NCT00283218